• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯乙胺与精神分裂症

Phenylethylamine and schizophrenia.

作者信息

O'Reilly R L, Davis B A

机构信息

Department of Psychiatry, University of Western Ontario, London, Canada.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jan;18(1):63-75. doi: 10.1016/0278-5846(94)90024-8.

DOI:10.1016/0278-5846(94)90024-8
PMID:7906896
Abstract
  1. The evidence that phenylethylamine (PEA) plays a role in the etiology of schizophrenia is reviewed. 2. PEA shares structural and physiological similarities with the amphetamines, the administration of which can induce a schizophrenia-like psychosis. 3. While there are a number of reports of high urinary PEA excretion in schizophrenic patients, the measurement of PEA in other body fluids and the measurement of phenylacetic acid (the major metabolite of PEA) has resulted in inconsistent findings. 4. The use of neuroleptic medication is a major confounding variable in most of the clinical studies. If PEA does have a role in the etiology of schizophrenia, the mechanism may involve PEAs ability to amplify dopamine responses.
摘要
  1. 本文综述了苯乙胺(PEA)在精神分裂症病因学中发挥作用的证据。2. PEA与安非他明在结构和生理上有相似之处,服用安非他明可诱发类似精神分裂症的精神病。3. 虽然有多项报告称精神分裂症患者尿中PEA排泄量高,但在其他体液中检测PEA以及检测苯乙酸(PEA的主要代谢产物)的结果并不一致。4. 在大多数临床研究中,使用抗精神病药物是一个主要的混杂变量。如果PEA确实在精神分裂症病因学中起作用,其机制可能涉及PEA放大多巴胺反应的能力。

相似文献

1
Phenylethylamine and schizophrenia.苯乙胺与精神分裂症
Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jan;18(1):63-75. doi: 10.1016/0278-5846(94)90024-8.
2
Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.精神分裂症患者和健康对照者脑脊液中的苯乙胺和苯乙酸
Arch Psychiatr Nervenkr (1970). 1983;232(6):463-71. doi: 10.1007/BF00344060.
3
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.精神分裂症和抑郁症中苯乙酸的排泄:人体内苯乙酸的来源
Biol Psychiatry. 1984 Feb;19(2):165-78.
4
Phenylethylamine in neuropsychiatric disorders.
Gen Pharmacol. 1983;14(4):385-90. doi: 10.1016/0306-3623(83)90020-4.
5
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):6-14. doi: 10.1176/jnp.7.1.6.
6
Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.精神分裂症患者的尿微量胺排泄及血小板单胺氧化酶活性
Psychiatry Res. 1987 Jul;21(3):229-36. doi: 10.1016/0165-1781(87)90027-8.
7
Biochemistry and the schizophrenia. Old concepts and new hypothesis.生物化学与精神分裂症。旧概念与新假说。
J Nerv Ment Dis. 1981 Feb;169(2):90-9.
8
[beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics].
Yakubutsu Seishin Kodo. 1989 Dec;9(4):335-48.
9
Discriminative stimulus properties of beta-phenylethylamine, deuterated beta-phenylethylamine, phenylethanolamine and some metabolites of phenylethylamine in rodents.
Pharmacol Biochem Behav. 1986 Jun;24(6):1547-53. doi: 10.1016/0091-3057(86)90483-1.
10
Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
Psychopharmacol Bull. 1980 Jan;16(1):52-4.

引用本文的文献

1
Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter-mediated nonquantal dopamine release.模拟信号对神经递质相互作用和行为的贡献:转运体介导的非量子多巴胺释放的作用。
Physiol Rep. 2021 Nov;9(21):e15088. doi: 10.14814/phy2.15088.
2
Progress in mechanistically novel treatments for schizophrenia.精神分裂症新机制治疗方法的进展。
RSC Med Chem. 2021 Jun 29;12(9):1459-1475. doi: 10.1039/d1md00096a. eCollection 2021 Sep 23.
3
Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.
SARS-CoV-2 诱导的肠脑轴改变的分子洞察。
Int J Mol Sci. 2021 Sep 28;22(19):10440. doi: 10.3390/ijms221910440.
4
Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.用于监测脆性X智力低下基因1前突变携带者脑病理生理学的血浆生物标志物
Front Mol Neurosci. 2016 Aug 12;9:71. doi: 10.3389/fnmol.2016.00071. eCollection 2016.
5
Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.四甲基吡嗪类似物CXC195通过PI3K/Akt/GSK3β通路保护大鼠免受脑缺血/再灌注诱导的细胞凋亡。
Neurochem Int. 2014 Jan;66:27-32. doi: 10.1016/j.neuint.2014.01.006. Epub 2014 Jan 22.
6
β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.β-苯乙胺需要多巴胺转运体来增加秀丽隐杆线虫多巴胺能神经元中的细胞外多巴胺。
Neurochem Int. 2014 Jul;73:27-31. doi: 10.1016/j.neuint.2013.10.010. Epub 2013 Oct 23.
7
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.自闭症谱系障碍和精神分裂症中 X 染色体突触基因的系统重测序。
Mol Psychiatry. 2011 Aug;16(8):867-80. doi: 10.1038/mp.2010.54. Epub 2010 May 18.
8
Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples.四个独立样本中苯丙氨酸羟化酶变异体与精神分裂症之间的趋同关联模式。
Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):560-9. doi: 10.1002/ajmg.b.30862.
9
Trace amine-associated receptor 1-Family archetype or iconoclast?痕量胺相关受体1——家族原型还是叛逆者?
Pharmacol Ther. 2007 Dec;116(3):355-90. doi: 10.1016/j.pharmthera.2007.06.007. Epub 2007 Jul 17.
10
Trace amines: identification of a family of mammalian G protein-coupled receptors.痕量胺:一类哺乳动物G蛋白偶联受体的鉴定
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71. doi: 10.1073/pnas.151105198. Epub 2001 Jul 17.